---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-012286"
form_type: "8-K"
ticker: null
cik: "0001402479"
company_name: "MedAvail Holdings, Inc."
filed_at: "2024-02-08T23:59:59+00:00"
generated_at: "2026-06-06T05:33:59.628338+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.95
calibrated_materiality_score: 0.95
confidence: "high"
source: SEC EDGAR
---

# MedAvail to be delisted from Nasdaq after Chapter 7 bankruptcy filing

## Summary
- Filed voluntary Chapter 7 bankruptcy petition on Feb 2, 2024 in Delaware.
- Nasdaq delisting notice cites public interest concerns and Chapter 7 filing.
- Trading suspended at open on Feb 13, 2024; company will not appeal.
- Form 25-NSE to be filed to remove common stock from Nasdaq listing.

## SEC filing metadata
- accession: 0001104659-24-012286
- form_type: 8-K
- cik: 0001402479
- company_name: MedAvail Holdings, Inc.
- filed_at: 2024-02-08T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.95
- calibrated_materiality_score: 0.95
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1402479/000110465924012286/0001104659-24-012286-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1402479/000110465924012286/tm245472d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-012286
- JSON: https://secwatch.observer/filing/0001104659-24-012286.json
- Plain text: https://secwatch.observer/filing/0001104659-24-012286.txt

## Key facts
- Listing & Compliance Notices
  MedAvail Holdings, Inc. received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Rules: 5101, 5110(b), IM-5101-1
  source text: : MedAvail Holdings, Inc. , Case No. 24-10148. On February 2, 2024, the Company received written notice (the “Delisting Notice”) from the staff of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, as a result of the Chapter 7 Filing and in accordance with Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, the staff of Nasdaq had determined that the Company’s common stock will be delisted from Nasdaq. In the Delisting Notice, the staff of Nasdaq referenced the Chapter 7 Filing and associated public interest concerns raised by it, concerns regarding the residual equity interest o
  evidence_url: https://www.sec.gov/Archives/edgar/data/1402479/000110465924012286/0001104659-24-012286-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.